Related stories

Implementation Measures of the "Rules of the People's Republic of China on Customs Protection of Intellectual Property Rights" Decision on Amendments to the Law of Judges of the People's Republic of China Zheng Jian Fa [2004] No. 67 -- Notice of the China Securities Regulatory Commission on Several Issues Concerning Regulation of Overseas Listing of Companies Affiliated to Domestic Listed Companies Rules for the Implementation of Regulations on the Management of Foreign Invested Financial Institutes for the People's Republic of China (the Rules) Anti-dumping Regulations of the People's Republic of China (Revised)

China Starts Human Trials of AIDS Vaccine

China, with 840,000 HIV carriers, began its first human trials of a new AIDS vaccine said an expert from the disease-prevention and control centre of south China's Guangxi Zhuang Autonomous Region.

A 20-year old man became the first volunteer to receive the AIDS vaccine therapy. Seven others followed him, four of them women. All volunteers have had a physical check-up. Chen Jie, vice director of the centre, said 49 volunteers aged between 18 and 50 will be take part in the trial. The clinical research has three phases, he said, the first lasting for 14 months. The second phase will test the immune nature and safety of the vaccine.

The State Food and Drug Administration approved the first clinical phase research of the new AIDS vaccine in November, 2004. The United Nations has said that the number of HIV/AIDS sufferers in China could rise to 10 million by 2010 unless serious steps are taken to fight the disease. There have been about 35 AIDS vaccine trials on humans throughout the world, most of which are still in their first phase.